What are the biomarkers for Sjögren's syndrome with interstitial lung disease (ILD)?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18952936
Cited by: 0

Abstract

Anti-Ro/SSA antibodies and anti-Ro52 are notable biomarkers for Sjögren's syndrome with interstitial lung disease, with emerging potential markers like CYSLTR1 and SIGLEC10 warranting further investigation.

Fields of Study & Subjects

Salivary Gland Disorders and Functions Systemic Lupus Erythematosus Research Systemic Sclerosis and Related Diseases

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
11 March 2026
Language
EN